ASPET Discovery
Издатель: Elsevier · ISSN 3050-5674 · 39 статей
- TCR- T Cell Therapy: A Revolution in Personalized Cancer Therapy
- ASPET Discovery launches!
- NEK2 inhibition alleviates lipopolysaccharide-induced endothelial injury
- Evaluation of molecular glue–induced neomorphic protein-protein interaction with a cell lysate–based time-resolved fluorescence resonance energy transfer assay
- In vitro and in silico pharmacological profiling of 3-(4,5-diaryl-1H-imidazol-2-yl)quinoline-2-amine hybrids
- Strain-dependent neuronal disposition and toxicity of paclitaxel in mice
- Hibiscus sabdariffa Linn. protects against cerebral ischemia-reperfusion injury via regulation of oxidative stress markers and inflammation
- Ecofriendly silver nanoparticle synthesis, physicochemical characterization from Datura stramonium, and its biological applications in Parkinson Drosophila model
- Cheating death: How a porphyrin transporter fuels survival in hypoxia
- Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia
- Quantitative structure-activity relationship-guided design and molecular modeling of anaplastic lymphoma kinase L1196M inhibitors: overcoming drug resistance through docking, ADMET (absorption, distribution, metabolism, excretion, and toxicity), and density functional theory studies
- Unveiling the therapeutic mechanisms of Shenshu powder in COVID-19 treatment: Insights from network pharmacology and experimental validation
- Levetiracetam: An antiseizure drug with unique neuroprotective properties
- Pharmacological modulation of the gut microbiota and endotoxemia: A next-generation approach to treating metabolic syndrome
- Integrative strategies in breast cancer therapy: Conventional approaches, emerging advances, and future challenges
- A new frontier: Terpenes in the fight against colon cancer
- A systematic review of preclinical studies of medicinal plants found in India targeting obesity
- Advances in computer-aided drug design: From molecular docking to artificial intelligence-driven therapeutic discovery
- Insights and perspectives into the etiology of TKI-induced cardiotoxicity
- PP2A regulation in acute myeloid leukemia: Mechanisms, stem cell biology, and therapeutic implication
- Behavioral pharmacology in biopharma drug discovery: With gratitude to its founders
- Emerging concepts on one-carbon metabolism as a unique and actionable vulnerability in cancer
- A soliloquy on synergy
- Liver imaging to investigate hepatocyte transporter–mediated drug-drug interactions
- Fatty acid–binding proteins as emerging immunometabolic regulators and therapeutic targets in multiple sclerosis and neurodegeneration: Promise, mechanistic gaps, and translational hurdles
- Phenotypic assays, high-throughput microscopy and high-content analysis in drug screening
- Flavan-3-gallate catechins in green tea (Camellia sinensis) reduce amiodarone solubility and dissolution in fasted state simulated intestinal fluid
- Methyl eugenol as a multitarget-directed ligand for Alzheimer disease: A promising lead for drug design
- In silico design of 3-methyl-3H-naphtho[1,2,3-de]quinoline-2,7-dione inhibitors against tuberculosis via docking and dynamics simulation techniques and pharmacokinetic evaluation
- Differential effects of acute versus repeated chemogenetic activation of the mesocorticolimbic dopamine pathway on cocaine choice in male and female TH:Cre rats